Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
What we are looking for: The Internal Displacement Monitoring Centre (IDMC) and the Joint Internal Displacement Profiling Service (JIPS) are merging. We are seeking an experienced and strategic Programme Manager to play a pivotal role in
Integrated Risk (IR) provides a Group-wide view of INGs risk profile, connecting governance, methodologies and risk insights to support senior and board-level decision-making. Within IR, Integrated Risk Oversight (IRO) focuses on oversight of credit risk models
Integrated Risk (IR) provides a Group-wide view of INGs risk profile, connecting governance, methodologies and risk insights to support senior and board-level decision-making. Within IR, Integrated Risk Oversight (IRO) focuses on oversight of credit risk models